Clinical practice of renal cell carcinoma treatment with nivolumab

被引：0
作者：
Potocki, Pawel M. [1 ]
Wysocki, Piotr J. [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Dept Oncol, Krakow, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2019年 / 15卷 / 05期
关键词：
kidney cancer; renal cell carcinoma; nivolumab; anti-PD-1; immunotherapy; checkpoint inhibitor; RANDOMIZED PHASE-3; CHECKMATE; 025; CANCER; EVEROLIMUS; IMMUNITY; SUNITINIB; BLOCKADE; EFFICACY; THERAPY; SAFETY;
D O I：
10.5603/OCP.2019.0002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Nivolumab alike other immune checkpoint inhibitors has been intensively developed during the last decade. Kidney cancer is among the neoplasm in treatment of which we have accumulated the most experience regarding nivolumab. As improves our understanding of the mechanisms underlying specific cellular immune response, thus improves our understanding of the place the nivolumab holds among other therapeutic options. Recent years brought development of innovative immunotherapy combinations as a method for improving immunotherapy efficacy. This review aims at providing practicing oncologists with key aspects of renal cell carcinoma treatment with nivolumab.
引用
收藏
页码：237 / 245
页数：9
相关论文
共 50 条
[31]   Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience [J].
Zhao, Joseph J. ;
Kumarakulasinghe, Nesaretnam Barr ;
Muthu, Vaishnavi ;
Lee, Matilda ;
Walsh, Robert ;
Low, Jia Li ;
Choo, Joan ;
Tan, Hon Lyn ;
Chong, Wan Qin ;
Ang, Yvonne ;
Chan, Gloria ;
Yong, Wei Peng ;
Huang, Yiqing ;
Ngoi, Natalie ;
Wong, Alvin .
ONCOLOGY, 2021, 99 (03) :192-202
[32]   Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review [J].
McGregor, Bradley ;
Mortazavi, Amir ;
Cordes, Lisa ;
Salabao, Cristina ;
Vandlik, Susan ;
Apolo, Andrea B. .
CANCER TREATMENT REVIEWS, 2022, 103
[33]   Cabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma [J].
Vitale, Maria Giuseppa ;
Nasso, Cecilia ;
Oltrecolli, Marco ;
Baldessari, Cinzia ;
Fanelli, Martina ;
Dominici, Massimo ;
Sabbatini, Roberto .
EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (11) :1183-1192
[34]   Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma [J].
Caner, Burcu ;
Ertas, Hulya ;
Ocak, Birol ;
Cubukcu, Erdem .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (07) :1645-1649
[35]   Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients [J].
Zhang, Tian ;
Pabla, Sarabjot ;
Lenzo, Felicia L. ;
Conroy, Jeffrey M. ;
Nesline, Mary K. ;
Glenn, Sean T. ;
Papanicolau-Sengos, Antonios ;
Burgher, Blake ;
Giamo, Vincent ;
Andreas, Jonathan ;
Wang, Yirong ;
Bshara, Wiam ;
Madden, Katherine G. ;
Shirai, Keisuke ;
Dragnev, Konstantin ;
Tafe, Laura J. ;
Gupta, Rajan ;
Zhu, Jason ;
Labriola, Matthew ;
McCall, Shannon ;
George, Daniel J. ;
Ghatalia, Pooja ;
Dayyani, Farshid ;
Edwards, Robert ;
Park, Michelle S. ;
Singh, Rajbir ;
Jacob, Robin ;
George, Saby ;
Xu, Bo ;
Zibelman, Matthew ;
Kurzrock, Razelle ;
Morrison, Carl .
ONCOIMMUNOLOGY, 2020, 9 (01)
[36]   Update on the treatment of metastatic renal cell carcinoma [J].
Medina Lopez, Rafael Antonio ;
Rivero Belenchon, Ines ;
Mazuecos-Quiros, Javier ;
Congregado-Ruiz, Carmen Belen ;
Counago, Felipe .
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2022, 13 (01) :1-8
[37]   Avelumab and axitinib combination therapy for the treatment of advanced renal cell carcinoma [J].
Soleimani, Maryam ;
Nappi, Lucia ;
Kollmannsberger, Christian .
FUTURE ONCOLOGY, 2020, 16 (36) :3021-3034
[38]   Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment [J].
Tada, Kouki ;
Daizumoto, Kei ;
Takahashi, Masayuki ;
Uehara, Hisanori ;
Tsuda, Megumi ;
Kusuhara, Yoshito ;
Fukawa, Tomoya ;
Yamamoto, Yasuyo ;
Yamaguchi, Kunihisa ;
Kanayama, Hiro-omi .
IJU CASE REPORTS, 2023, 6 (01) :41-44
[39]   Sorafenib in renal cell carcinoma [J].
Angel Arranz, Jose ;
Angel Climent, Miguel ;
Luis Gonzalez-Larriba, Jose ;
Leon, Luis ;
Pablo Maroto, Jose .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 80 (02) :314-322
[40]   Case of complete response to neoadjuvant therapy using nivolumab in a patient with metastatic renal cell carcinoma [J].
Ikarashi, Daiki ;
Kato, Yoichiro ;
Katagiri, Hirokatsu ;
Takahara, Takeshi ;
Uesugi, Noriyuki ;
Shiomi, Ei ;
Sugimura, Jun ;
Nitta, Hiroyuki ;
Sugai, Tamotsu ;
Obara, Wataru .
INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (06) :630-632
12345